Cargando…

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis

As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Deltombe, Olivier, Van Biesen, Wim, Glorieux, Griet, Massy, Ziad, Dhondt, Annemieke, Eloot, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626712/
https://www.ncbi.nlm.nih.gov/pubmed/26426048
http://dx.doi.org/10.3390/toxins7103933
_version_ 1782398149198872576
author Deltombe, Olivier
Van Biesen, Wim
Glorieux, Griet
Massy, Ziad
Dhondt, Annemieke
Eloot, Sunny
author_facet Deltombe, Olivier
Van Biesen, Wim
Glorieux, Griet
Massy, Ziad
Dhondt, Annemieke
Eloot, Sunny
author_sort Deltombe, Olivier
collection PubMed
description As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Blood samples were taken either during the routine ambulatory visit (CKD patients) or from blood inlet and outlet line during dialysis (HD patients). Total (C(T)) and free concentrations were determined of p-cresylglucuronide (pCG), hippuric acid (HA), indole-3-acetic acid (IAA), indoxyl sulfate (IS) and p-cresylsulfate (pCS), and their percentage protein binding (%PB) was calculated. In CKD patients, %PB/C(T) resulted in a positive correlation (all p < 0.001) with renal function for all five uremic toxins. In HD patients, %PB was increased after 120 min of dialysis for HA and at the dialysis end for the stronger (IAA) and the highly-bound (IS and pCS) solutes. During one passage through the dialyzer at 120 min, %PB was increased for HA (borderline), IAA, IS and pCS. These findings explain why protein-bound solutes are difficult to remove by dialysis: a combination of the fact that (i) only the free fraction can pass the filter and (ii) the equilibrium, as it was pre-dialysis, cannot be restored during the dialysis session, as it is continuously disturbed.
format Online
Article
Text
id pubmed-4626712
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46267122015-11-12 Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis Deltombe, Olivier Van Biesen, Wim Glorieux, Griet Massy, Ziad Dhondt, Annemieke Eloot, Sunny Toxins (Basel) Article As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Blood samples were taken either during the routine ambulatory visit (CKD patients) or from blood inlet and outlet line during dialysis (HD patients). Total (C(T)) and free concentrations were determined of p-cresylglucuronide (pCG), hippuric acid (HA), indole-3-acetic acid (IAA), indoxyl sulfate (IS) and p-cresylsulfate (pCS), and their percentage protein binding (%PB) was calculated. In CKD patients, %PB/C(T) resulted in a positive correlation (all p < 0.001) with renal function for all five uremic toxins. In HD patients, %PB was increased after 120 min of dialysis for HA and at the dialysis end for the stronger (IAA) and the highly-bound (IS and pCS) solutes. During one passage through the dialyzer at 120 min, %PB was increased for HA (borderline), IAA, IS and pCS. These findings explain why protein-bound solutes are difficult to remove by dialysis: a combination of the fact that (i) only the free fraction can pass the filter and (ii) the equilibrium, as it was pre-dialysis, cannot be restored during the dialysis session, as it is continuously disturbed. MDPI 2015-09-28 /pmc/articles/PMC4626712/ /pubmed/26426048 http://dx.doi.org/10.3390/toxins7103933 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Deltombe, Olivier
Van Biesen, Wim
Glorieux, Griet
Massy, Ziad
Dhondt, Annemieke
Eloot, Sunny
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title_full Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title_fullStr Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title_full_unstemmed Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title_short Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
title_sort exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626712/
https://www.ncbi.nlm.nih.gov/pubmed/26426048
http://dx.doi.org/10.3390/toxins7103933
work_keys_str_mv AT deltombeolivier exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis
AT vanbiesenwim exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis
AT glorieuxgriet exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis
AT massyziad exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis
AT dhondtannemieke exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis
AT elootsunny exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis